US BANCORP \DE\ - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 223 filers reported holding AXSOME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,698,705
-3.4%
138,771
-0.7%
0.02%0.0%
Q2 2023$10,041,142
+20.2%
139,732
+3.1%
0.02%
+14.3%
Q1 2023$8,357,086
-21.9%
135,491
-2.4%
0.01%
-26.3%
Q4 2022$10,705,027
+59.5%
138,792
-7.7%
0.02%
+35.7%
Q3 2022$6,711,000
-33.3%
150,406
-42.8%
0.01%
-30.0%
Q2 2022$10,068,000
+12485.0%
262,882
+13464.6%
0.02%
Q1 2022$80,000
-80.5%
1,938
-82.2%
0.00%
-100.0%
Q4 2021$411,000
+12.3%
10,876
-2.0%
0.00%0.0%
Q3 2021$366,000
-42.9%
11,100
+16.7%
0.00%0.0%
Q2 2021$641,000
+20.7%
9,510
+1.5%
0.00%0.0%
Q1 2021$531,000
-28.0%
9,374
+3.5%
0.00%
-50.0%
Q4 2020$738,000
+22.8%
9,061
+7.5%
0.00%
+100.0%
Q3 2020$601,000
+165.9%
8,431
+206.2%
0.00%0.0%
Q2 2020$226,000
+23.5%
2,753
-11.3%
0.00%0.0%
Q1 2020$183,000
-4.2%
3,104
+68.1%
0.00%
Q4 2019$191,000
+664.0%
1,846
+54.7%
0.00%
Q3 2019$25,000
+19.0%
1,193
+45.1%
0.00%
Q2 2019$21,0008220.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,132,645$37,332,00032.86%
MORGAN JESS S & CO INC 113,430$3,739,0002.47%
Fairmount Funds Management LLC 187,598$6,183,0002.25%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,423,653$46,924,0001.43%
WMS Partners, LLC 250,000$8,240,0001.21%
Beck Bode, LLC 102,127$3,366,0000.94%
RTW INVESTMENTS, LP 1,616,497$53,280,0000.80%
MPM BioImpact LLC 110,155$3,631,0000.56%
Endurant Capital Management LP 52,048$1,716,0000.39%
Bellevue Group AG 752,945$24,817,0000.25%
View complete list of AXSOME THERAPEUTICS INC shareholders